SLC31A1 and Thrombocytopenia: In summary, this pharmacogenetic study on advanced NSCLC patients with platinum-based chemotherapy has identified linked variants of platinum import transporter SLC31A1 gene that were associated with severe hematological toxicities such as thrombocytopenia and shorter survival, one of which decreased gene expression through modulating microRNA-3′UTR interaction.